Dr. Sarah Hartz is Assistant Professor of Psychiatry at Washington University in St. Louis, MO. Dr. Hartz holds a PhD in Statistics from the University of Illinois Urbana-Champaign (2003), and she performed her residency in Psychiatry at the University of Iowa Hospitals and Clinics and Washington University/Barnes-Jewish Hospital (2005-2009). Dr. Hartz is currently a physician scientist who has combined her background in statistics and genetics with her psychiatric training to better understand the genetics of substance dependence. Dr. Hartz's current research interests include 1) genetics of comorbidity between substance use disorders and other severe mental illness, 2) return of genetic results to research participants, and 3) application of quantitative methodologies to addiction genetics.
- Johnson, L, Ma, Y, Fisher, SL, Ramsey, AT, Chen, LS, Hartz, SM, Culverhouse, RC, Grucza, RA, Saccone, NL, Baker, TB et al.. E-cigarette Usage Is Associated With Increased Past-12-Month Quit Attempts and Successful Smoking Cessation in Two US Population-Based Surveys. Nicotine Tob. Res. 2018; : . PubMed PMID:30304476 .
- Hartz, SM, Oehlert, M, Horton, AC, Grucza, RA, Fisher, SL, Culverhouse, RC, Nelson, KG, Sumerall, SW, Neal, PC, Regnier, P et al.. Daily Drinking Is Associated with Increased Mortality. Alcohol. Clin. Exp. Res. 2018; : . PubMed PMID:30281161 .
- Salloum, NC, Buchalter, EL, Chanani, S, Espejo, G, Ismail, MS, Laine, RO, Nageeb, M, Srivastava, AB, Trapp, N, Trillo, L et al.. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics 2018; 19 (10): 861-871. PubMed PMID:29914292 .
- Ramsey, AT, Chen, LS, Hartz, SM, Saccone, NL, Fisher, SL, Proctor, EK, Bierut, LJ. Toward the implementation of genomic applications for smoking cessation and smoking-related diseases. Transl Behav Med 2018; 8 (1): 7-17. PubMed PMID:29385591 PubMed Central PMC6065540.
- Hartz, SM, Horton, AC, Oehlert, M, Carey, CE, Agrawal, A, Bogdan, R, Chen, LS, Hancock, DB, Johnson, EO, Pato, CN et al.. Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. Biol. Psychiatry 2017; 82 (10): 709-715. PubMed PMID:28739213 PubMed Central PMC5643224.
- Hartz, SM. Capsule Commentary on Gryczynski et al., Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. J Gen Intern Med 2017; 32 (9): 1026. PubMed PMID:28721534 PubMed Central PMC5570757.
- Hartz, SM, Horton, AC, Hancock, DB, Baker, TB, Caporaso, NE, Chen, LS, Hokanson, JE, Lutz, SM, Marazita, ML, McNeil, DW et al.. Genetic correlation between smoking behaviors and schizophrenia. Schizophr. Res. 2018; 194 : 86-90. PubMed PMID:28285025 PubMed Central PMC5811408.
- Carey, CE, Agrawal, A, Bucholz, KK, Hartz, SM, Lynskey, MT, Nelson, EC, Bierut, LJ, Bogdan, R. Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement. Front Genet 2016; 7 : 149. PubMed PMID:27574527 PubMed Central PMC4983546.
- Hartz, SM, Quan, T, Ibiebele, A, Fisher, SL, Olfson, E, Salyer, P, Bierut, LJ. The significant impact of education, poverty, and race on Internet-based research participant engagement. Genet. Med. 2017; 19 (2): 240-243. PubMed PMID:27467456 PubMed Central PMC5274598.
- Estrada, E, Hartz, SM, Tran, J, Hilty, DM, Sklar, P, Smoller, JW, Genomic Psychiatry Cohort Consortium, Pato, MT, Pato, CN. Nicotine dependence and psychosis in Bipolar disorder and Schizoaffective disorder, Bipolar type. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2016; 171 (4): 521-4. PubMed PMID:26467098 PubMed Central PMC4950843.